-
-
Call more information
660-596-2224 -
Authors: Aranke M et al Pract Pain Manag. 2023 January/February;23(1). Introduction Chemotherapy-induced peripheral neuropathy (CIPN) affects between 40% and 70% of individuals undergoing chemotherapy and may significantly affect quality of life by worsening symptomatic clusters, such as psychological distress, fatigue-related pain, and abdominal discomfort.¹˒² There are several proposed mechanisms for CIPN. These range from the […]
Read MoreAuthor: Enrico Giustiniano, M.D.; Fulvio Nisi, M.D. Anesthesiology January 2023. To the Editor: We read with interest the article by Enevoldsen and Vistisen about the predictive model of intraoperative hypotension. Regarding the criticism the authors made about what they named “gray-zone outcome,” we would like to provide some comments. The Hypotension Prediction Index is a new parameter […]
Read MoreAutors: Johannes Enevoldsen, M.D. et al Anesthesiology January 2023. In Reply: We have read the interesting comment by Giustiniano and Nisi about our article. The authors highlight that the diastolic arterial blood pressure can decrease significantly when the Hypotension Prediction Index (hereafter the Index) reaches approximately 50 and argue for the possible need for treatment when diastolic arterial […]
Read MoreAuthors: Hao Xiao, M.S. et al Anesthesiology January 2023. Background Chlorhexidine generally has a good safety profile. However, allergic reactions are reported with increasing frequency. In China, it is rarely reported, and its characteristics are unknown. The purpose of this study was to summarize the experience of a Chinese allergy centre with chlorhexidine allergy. Methods […]
Read MoreAUTHORS: Cohen, William G. BA et al Anesthesia & Analgesia November 02, 2022. BACKGROUND: Ketorolac-refractory pain behavior following bilateral myringotomy and pressure equalization tube placement (BMT) is associated with the absence of middle ear fluid. Intraoperative fentanyl/ketorolac affords more reliable pain control than ketorolac alone. We hypothesized that middle ear condition would correlate with postoperative […]
Read MoreAuthor: Doheny K. Pract Pain Manag. 2023 January/February;23(1). Migraine affects at least 39 million US adults, according to the Association of Migraine Disorders,¹ causing lost workdays, time away from family, and other quality of life issues. Worldwide, about 10% of people are affected by migraine and women are three times as likely to be affected […]
Read MoreAuthor: Hannah Flynn MedicalNewsToday Cluster headaches affect about one in 1,000 people and typically, the condition impacts more men than women. The pain associated with this condition is so severe that it can be seriously limiting and disabling. A recent study has shown that while the majority of people with the condition are male, females are more […]
Read MoreAuthor: Paige Twenter Becker’s Hospital Review Between two types of local anesthetics, there are 132 in short supply and 13 available, according to the American Society of Health-System Pharmacists. Here’s how the shortages of bupivacaine and lidocaine break down: Twenty bupivacaine injections from Pfizer are back-ordered because of manufacturing delays, and resupply dates fall between January and June. The […]
Read MoreAuthor: Lalitha Sundararaman, MBBS, MD ASA Monitor January 2023, Vol. 87, 29. OPIOID CRISIS I have had the privilege of being part of the ASA Monitor Editorial Board for a few years, and one article that has touched my heart is the wrenching story of Dr. Bonnie Milas and her efforts in collaboration with the ASA Committee on […]
Read MoreAuthor: Avery Hurt Piratical Pain Management Jan/Feb 2023 Chronic pelvic pain can be a challenge to treat for many reasons, not least because it manifests in myriad ways, making it difficult even to nail down a definition of the term. The pathology behind chronic pelvic pain (CPP) is equally complex. Even the American College of […]
Read More